Cardiology

Many at high cardiovascular risk still not on statins

(HealthDay)—Many individuals at high risk for cardiovascular events, such as those with coronary artery disease, diabetes, or both, are not receiving statins, according to research published in the May/June issue of the ...

Cardiology

Darapladib falls short in chronic coronary heart disease

The novel inflammation inhibitor darapladib showed no primary-endpoint advantage over placebo in patients with chronic coronary heart disease treated with a high level of background care, although it did suggest possible ...

Cardiology

Long term exposure to air pollution linked to coronary events

Long term exposure to particulate matter in outdoor air is strongly linked to heart attacks and angina, and this association persists at levels of exposure below the current European limits, suggests research conducted at ...

Cardiology

Prognostic value of lipoprotein (a) with low cholesterol unclear

(HealthDay)—Lipoprotein (a) (Lp[a]) has utility in assessing cardiovascular risk in patients with coronary artery disease (CAD); however, the prognostic value of Lp(a) in patients with low cholesterol levels remains unclear, ...

Cardiology

Results of the FREEDOM sub study reported

According to a recent study of diabetic patients who underwent revascularization for multi-vessel coronary artery disease (CAD), patients treated with insulin experienced more major adverse cardiovascular events after revascularization ...

Cardiology

Results of the SORT-OUT VI trial presented

A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with biodegradable polymers were associated with low major adverse coronary events, demonstrating the non-inferiority of the biocompatible ...

page 7 from 18